New opportunities for identifying the risk of cardiovascular events in young people: the role of familial hypercholesterolemia
Open Access
- 5 January 2023
- journal article
- research article
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 27 (12) , 5294
Abstract
A search was made for publications on modern methods for determining cardiovascular risk in young people with positive family history for early cardiovascular events. The use of various screening options allows timely identification of patients with heterozygous familial hypercholesterolemia who have a high cardiovascular risk. The most effective method is cascade screening. Cardiovascular risk assessment systems that include a family history of early cardiovascular events and lipid profiles in individuals under 40 years of age provide prevention of atherosclerosis. In the diagnosis of risk, the lipoprotein (a) is of particular clinical importance, elevated concentrations of which are associated with a high risk of vascular damage and an unfavorable course of atherosclerosis.Keywords
This publication has 39 references indexed in Scilit:
- Targeted sequencing in patients with clinically diagnosed hereditary lipid metabolism disorder and acute coronary syndromeBulletin of Russian State Medical University, 2018
- ClinVar database of global familial hypercholesterolemia‐associated DNA variantsHuman Mutation, 2018
- Familial hypercholesterolemia in very young myocardial infarctionScientific Reports, 2018
- The Role of Lipoprotein(a) in the Development of Peripheral and Carotid AtherosclerosisKardiologiia, 2018
- Genetics of Dyslipidemia and Ischemic Heart DiseaseCurrent Cardiology Reports, 2017
- Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatmentEuropean Heart Journal, 2015
- Ten-Year Follow-up After Initiation of Statin Therapy in Children With Familial HypercholesterolemiaJAMA, 2014
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis SocietyEuropean Heart Journal, 2013
- Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control studyThe Lancet, 2013
- Lipoprotein(a) as a modifier of fibrin clot permeability and susceptibility to lysisJournal of Thrombosis and Haemostasis, 2006